| Ticker Details |
Repligen Corporation
Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$8.12B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.30 | 3.17%
|
| Avg Daily Range (30 D): |
$3.29 | 2.52%
|
| Avg Daily Range (90 D): |
$2.82 | 2.28%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.32M |
| Avg Daily Volume (30 D): |
.84M |
| Avg Daily Volume (90 D): |
.88M |
| Trade Size |
| Avg Trade Size (Sh.): |
68 |
| Avg Trade Size (Sh.) (30 D): |
48 |
| Avg Trade Size (Sh.) (90 D): |
47 |
| Institutional Trades |
| Total Institutional Trades: |
6,323 |
| Avg Institutional Trade: |
$5.21M |
| Avg Institutional Trade (30 D): |
$8.12M |
| Avg Institutional Trade (90 D): |
$6.96M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.73M |
| Avg Closing Trade (30 D): |
$22.57M |
| Avg Closing Trade (90 D): |
$17M |
| Avg Closing Volume: |
64.93K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$.92
|
$.15
|
$.24
|
|
Diluted EPS
|
$.9
|
$.15
|
$.23
|
|
Revenue
|
$763.34M
|
$194.26M
|
$197.91M
|
|
Gross Profit
|
$403.77M
|
$108.28M
|
$103.83M
|
|
Net Income / Loss
|
$51.4M
|
$8.33M
|
$13.29M
|
|
Operating Income / Loss
|
$64.53M
|
$15.94M
|
$17.87M
|
|
Cost of Revenue
|
$359.57M
|
$85.97M
|
$94.08M
|
|
Net Cash Flow
|
$-113.37M
|
$18.76M
|
$-182.85M
|
|
PE Ratio
|
|
|
|
|
|
|
